News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
878,343 Results
Type
Article (88485)
Company Profile (813)
Press Release (789015)
Multimedia
Podcasts (224)
Webinars (34)
Section
Business (233458)
Career Advice (4156)
Deals (39933)
Drug Delivery (172)
Drug Development (91583)
Employer Resources (207)
FDA (18496)
Job Trends (17465)
News (398426)
Policy (40014)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (3042)
Academic (2)
Accelerated approval (48)
Adcomms (37)
Allergies (179)
Alliances (56986)
ALS (213)
Alzheimer's disease (1903)
Antibody-drug conjugate (ADC) (477)
Approvals (18760)
Artificial intelligence (773)
Autoimmune disease (274)
Automation (57)
Bankruptcy (407)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (231)
Biotechnology (486)
Bladder cancer (192)
Brain cancer (78)
Breast cancer (755)
Cancer (5963)
Cardiovascular disease (516)
Career advice (3587)
Career pathing (48)
CAR-T (345)
CDC (73)
Celiac Disease (2)
Cell therapy (946)
Cervical cancer (46)
Clinical research (78157)
Collaboration (2194)
Company closure (7)
Compensation (1367)
Complete response letters (100)
COVID-19 (3021)
CRISPR (112)
C-suite (1132)
Cystic fibrosis (161)
Data (7652)
Decentralized trials (3)
Denatured (84)
Depression (181)
Dermatology (72)
Diabetes (609)
Diagnostics (7469)
Digital health (60)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (384)
Drug pricing (240)
Drug shortages (39)
Duchenne muscular dystrophy (291)
Earnings (101536)
Editorial (74)
Employer branding (25)
Employer resources (174)
Events (137035)
Executive appointments (1137)
FDA (22228)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (34)
Funding (1797)
Gene editing (243)
Generative AI (85)
Gene therapy (778)
GLP-1 (1226)
Government (5527)
Grass and pollen (8)
Guidances (407)
Healthcare (21063)
HIV (85)
Huntington's disease (58)
IgA nephropathy (98)
Immunology and inflammation (335)
Immuno-oncology (98)
Indications (168)
Infectious disease (3390)
Inflammatory bowel disease (227)
Inflation Reduction Act (17)
Influenza (145)
Intellectual property (289)
Interviews (818)
IPO (17982)
IRA (61)
Job creations (5205)
Job search strategy (2870)
JPM (73)
Kidney cancer (21)
Labor market (109)
Layoffs (673)
Leadership (48)
Legal (10169)
Liver cancer (106)
Longevity (33)
Lung cancer (794)
Lymphoma (427)
Machine learning (60)
Management (66)
Manufacturing (1080)
MASH (197)
Medical device (15186)
Medtech (15278)
Mergers & acquisitions (23166)
Metabolic disorders (1636)
mRNA (231)
Multiple sclerosis (190)
NASH (24)
Neurodegenerative disease (445)
Neuropsychiatric disorders (121)
Neuroscience (3492)
Neurotech (2)
NextGen: Class of 2026 (7713)
Non-profit (5131)
Now hiring (76)
Obesity (796)
Opinion (364)
Ovarian cancer (213)
Pain (264)
Pancreatic cancer (295)
Parkinson's disease (377)
Partnered (39)
Patents (598)
Patient recruitment (660)
Peanut (66)
People (67591)
Pharmaceutical (138)
Pharmacy benefit managers (36)
Phase 1 (24151)
Phase 2 (33939)
Phase 3 (25529)
Pipeline (7901)
Policy (378)
Postmarket research (3556)
Preclinical (10864)
Press Release (72)
Prostate cancer (301)
Psychedelics (64)
Radiopharmaceuticals (345)
Rare diseases (1146)
Real estate (7450)
Recruiting (81)
Regulatory (29879)
Reports (76)
Research institute (2761)
Resumes & cover letters (653)
Rett syndrome (35)
RNA editing (25)
RSV (98)
Schizophrenia (185)
Series A (299)
Series B (220)
Service/supplier (30)
Sickle cell disease (117)
Special edition (30)
Spinal muscular atrophy (186)
Sponsored (53)
Startups (4354)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (137)
Vaccines (1248)
Venture capital (115)
Weight loss (549)
Women's health (125)
Worklife (24)
Date
Today (128)
Last 7 days (797)
Last 30 days (2992)
Last 365 days (33211)
2026 (10675)
2025 (33227)
2024 (38126)
2023 (42567)
2022 (53929)
2021 (58723)
2020 (57665)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1294)
Alabama (100)
Alaska (7)
Arizona (379)
Arkansas (16)
Asia (51985)
Australia (9141)
California (13193)
Canada (3748)
China (1396)
Colorado (569)
Connecticut (583)
Delaware (401)
Europe (119749)
Florida (1955)
Georgia (432)
Hawaii (4)
Idaho (69)
Illinois (1133)
India (96)
Indiana (619)
Iowa (25)
Japan (530)
Kansas (138)
Kentucky (53)
Louisiana (45)
Maine (87)
Maryland (1620)
Massachusetts (9635)
Michigan (397)
Minnesota (743)
Mississippi (7)
Missouri (160)
Montana (37)
Nebraska (30)
Nevada (144)
New Hampshire (92)
New Jersey (3534)
New Mexico (33)
New York (3493)
North Carolina (1795)
North Dakota (10)
Northern California (6466)
Ohio (408)
Oklahoma (26)
Oregon (55)
Pennsylvania (2635)
Puerto Rico (29)
Rhode Island (53)
South America (1668)
South Carolina (87)
South Dakota (2)
Southern California (5149)
Tennessee (210)
Texas (2132)
United States (47425)
Utah (396)
Vermont (1)
Virginia (336)
Washington D.C. (88)
Washington State (1092)
West Virginia (4)
Wisconsin (148)
Wyoming (2)
There are 878,343 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug pricing
Regeneron finally joins Trump’s drug pricing push while notching landmark approval
Of the 17 companies that were implored by the White House last July to apply Most Favored Nation pricing to their drugs, Regeneron is the last to agree—the same day the FDA greenlit its gene therapy for hearing loss in kids.
April 24, 2026
·
2 min read
·
Tristan Manalac
Press Releases
CORRECTING and REPLACING Samsung Epis Holdings Reports First Quarter 2026 Financial Results
April 24, 2026
·
5 min read
Press Releases
Evotec Announces Chief Financial Officer Transition
April 24, 2026
·
5 min read
Press Releases
Interim Report January - March 2026
April 24, 2026
·
3 min read
Press Releases
Vistin Pharma ASA: First quarter 2026 financial results
April 24, 2026
·
1 min read
Press Releases
CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study
April 24, 2026
·
8 min read
Press Releases
The top 250 cancer specialists converge in Belgium to push the frontiers of proton therapy
April 24, 2026
·
2 min read
Press Releases
Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants
April 24, 2026
·
8 min read
Press Releases
FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss Under National Priority Voucher Program
April 24, 2026
·
4 min read
Press Releases
Sensient Declares Dividend - April 23, 2026
April 24, 2026
·
1 min read
1 of 87,835
Next
